Akseli Hemminki Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
REPL | D | Replimune Group, Inc. | -3.35 | |
CLDI | F | Calidi Biotherapeutics, Inc. | -4.20 |
Related Industries: Biotechnology
Related Stock Lists:
Biotechnology
Cancer
Oncolytic Virus
Solid Tumors
Virotherapy
Cancer Immunotherapy
Cancer Treatment
Cell Biology
Cell Therapy
Clinical Medicine
Experimental Cancer Treatments
Glioma
Immune System
Immunotherapy
Immunotherapy Products
Medicine
Metastatic Disease
Rp1
Stem Cell
Transgene Sa
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.49 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 0.84 | |
ILDR | A | First Trust Innovation Leaders ETF | 0.44 | |
SBIO | D | ALPS Medical Breakthroughs ETF | 0.39 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.14 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Biotechnology
Cancer
Oncolytic Virus
Solid Tumors
Virotherapy
Cancer Immunotherapy
Cancer Treatment
Cell Biology
Cell Therapy
Clinical Medicine
Experimental Cancer Treatments
Glioma
Immune System
Immunotherapy
Immunotherapy Products
Medicine
Metastatic Disease
Rp1
Stem Cell
Transgene Sa
- Akseli Hemminki
Akseli Hemminki (1973-07-27) July 27, 1973 (Helsinki) is a Finnish specialist in Oncology and Radiotherapy, Professor of Oncology and founder of two biotechnology companies.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles